跳到主要內容

Sing George L 的 Form 4 申報

Regeneron Pharmaceuticals, Inc.REGN,2026/11/4 申報

申報編號
0001225471-26-000004
申報時間
2026/11/4 16:11 ET
交易日
2026/11/2
申報延遲
2 天
10b5-1 計畫
沒有勾選

這份申報列了 11 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $2,038 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Sing George LCIK 0001225471董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2026/11/2Common StockM行使選擇權取得+7,830$376.69+$2,949,482.738,837直接
2026/11/2Common StockM行使選擇權取得+7,439$380.95+$2,833,887.0546,276直接
2026/11/2Common StockS賣出處分−1,224$960.57F1−$1,175,737.6845,052直接
2026/11/2Common StockS賣出處分−540$961.85F2−$519,39944,512直接
2026/11/2Common StockS賣出處分−2,522$962.61F3−$2,427,702.4241,990直接
2026/11/2Common StockS賣出處分−4,338$963.47F4−$4,179,532.8637,652直接
2026/11/2Common StockS賣出處分−2,670$964.57F5−$2,575,401.934,982直接
2026/11/2Common StockS賣出處分−7,073$965.38F6−$6,828,132.7427,909直接
2026/11/2Common StockS賣出處分−1,522$966.27F7−$1,470,662.9426,387直接
2026/11/2Common StockS賣出處分−1,040$967.07F8−$1,005,752.825,347直接
2026/11/2Common StockS賣出處分−200$970.18F9−$194,03625,147直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2026/11/2Common StockM行使選擇權處分−7,830$0.00$00直接
2026/11/2Common StockM行使選擇權處分−7,439$0.00$00直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Represents volume-weighted average price of sales of 1,224 shares of Company stock on November 2, 2026 at prices ranging from $960.03 to $960.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F2

Represents volume-weighted average price of sales of 540 shares of Company stock on November 2, 2026 at prices ranging from $961.76 to $961.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F3

Represents volume-weighted average price of sales of 2,522 shares of Company stock on November 2, 2026 at prices ranging from $962.07 to $962.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F4

Represents volume-weighted average price of sales of 4,338 shares of Company stock on November 2, 2026 at prices ranging from $963.00 to $963.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F5

Represents volume-weighted average price of sales of 2,670 shares of Company stock on November 2, 2026 at prices ranging from $964.10 to $964.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Represents volume-weighted average price of sales of 7,073 shares of Company stock on November 2, 2026 at prices ranging from $965.00 to $965.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F7

Represents volume-weighted average price of sales of 1,522 shares of Company stock on November 2, 2026 at prices ranging from $966.02 to $966.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F8

Represents volume-weighted average price of sales of 1,040 shares of Company stock on November 2, 2026 at prices ranging from $967.00 to $967.26. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

F9

Represents volume-weighted average price of sales of 200 shares of Company stock on November 2, 2026 at prices ranging from $970.16 to $970.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 2, 2026 at each separate price.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)